X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4) 4
adult (3) 3
chemotherapy (3) 3
clinical trials (3) 3
female (3) 3
index medicus (3) 3
internal medicine (3) 3
male (3) 3
middle aged (3) 3
oncology (3) 3
abridged index medicus (2) 2
aged (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
clinical outcomes (2) 2
epidemiology (2) 2
free survival (2) 2
hematology (2) 2
immunotherapy (2) 2
leukemia, lymphocytic, chronic, b-cell - drug therapy (2) 2
medicine, general & internal (2) 2
minimal residual disease (2) 2
multicenter (2) 2
prognosis (2) 2
stem-cell transplantation (2) 2
survival (2) 2
tumors (2) 2
1st-line treatment (1) 1
[ sdv.can ] life sciences [q-bio]/cancer (1) 1
[sdv.can] life sciences [q-bio]/cancer (1) 1
[sdv.can]life sciences [q-bio]/cancer (1) 1
acute lymphoblastic leukemia (1) 1
acute lymphoblastic-leukemia (1) 1
adenocarcinoma (1) 1
aged, 80 and over (1) 1
alemtuzumab (1) 1
analysis (1) 1
anthracyclines (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal, humanized (1) 1
antibodies, neoplasm - administration & dosage (1) 1
antibodies, neoplasm - adverse effects (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - adverse effects (1) 1
bacterial infections (1) 1
bendamustine hydrochloride - administration & dosage (1) 1
bone-marrow-transplantation (1) 1
campath-1h therapy (1) 1
cancer (1) 1
cancer therapies (1) 1
chemoradiotherapy (1) 1
chop (1) 1
chronic lymphocytic leukemia (1) 1
chronic lymphocytic-leukemia (1) 1
cisplatin (1) 1
clinical-significance (1) 1
cll (1) 1
cmv (1) 1
colleges & universities (1) 1
combination (1) 1
combined modality therapy (1) 1
comorbidity (1) 1
confidence intervals (1) 1
consolidation (1) 1
control methods (1) 1
cyclophosphamide (1) 1
cyclophosphamide - administration & dosage (1) 1
cyclophosphamide - therapeutic use (1) 1
cytarabine - administration & dosage (1) 1
cytarabine - adverse effects (1) 1
disease-free survival (1) 1
doxorubicin - therapeutic use (1) 1
epirubicin (1) 1
esophageal (1) 1
esophageal cancer (1) 1
esophagus (1) 1
flow-cytometry (1) 1
fludarabine (1) 1
follicular lymphoma (1) 1
follow-up (1) 1
follow-up studies (1) 1
frontline fludarabine (1) 1
further section (1) 1
genomic aberrations (1) 1
germany (1) 1
hematology, oncology and palliative medicine (1) 1
hematopoietic stem cell transplantation - methods (1) 1
ibrutinib (1) 1
immunosuppressive agents - administration & dosage (1) 1
immunosuppressive agents - adverse effects (1) 1
indolent (1) 1
infection - etiology (1) 1
infections (1) 1
infusion (1) 1
initial therapy (1) 1
interactive systems (1) 1
international agencies (1) 1
intravenous administration (1) 1
intravenous infusion (1) 1
laboratories (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 7, pp. 928 - 942
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10044, pp. 565 - 575
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 1487 - 1487
Abstract Introduction In acute leukemias, specific cytogenetic aberrations frequently correlate with myeloid or lymphoid phenotype of blasts and influence risk... 
Journal Article
The Lancet, ISSN 0140-6736, 05/2019, Volume 393, Issue 10184, pp. 1948 - 1957
Journal Article
Leukemia, ISSN 0887-6924, 06/2004, Volume 18, Issue 6, pp. 1093 - 1101
Journal Article
Medizinische Klinik, ISSN 0723-5003, 12/2008, Volume 103, Issue 12, pp. 843 - 859
Bei einem 67-jährigen Mann wird im August 2000 die Diagnose eines klassischen Mantelzelllymphoms mit generalisiertem Lymphknotenbefall ohne B-Symptomatik... 
Medicine & Public Health | Internal Medicine | Medicine/Public Health, general
Journal Article
Oncology Research and Treatment, ISSN 2296-5270, 11/2008, Volume 31, Issue 5, pp. 40 - 40
Journal Article
Oncology Research and Treatment, ISSN 2296-5270, 11/2008, Volume 31, Issue 5, pp. 14 - 18
Ein standardisiertes Vorgehen gibt es bei primär nichtresektablen Lebermetastasen derzeit nicht. Wichtig ist ein interdisziplinärer Therapieansatz, um für... 
Paper
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.